XBiotech Inc. — Director's Dealing 2018

Dec 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-12-24

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-24	Common Stock	P	24838	$5.882	Acquired	27738	Indirect
2018-12-26	Common Stock	P	3600	$4.9989	Acquired	31338	Indirect
2018-12-27	Common Stock	P	1364	$4.9163	Acquired	32702	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3398600	Direct
Common Stock	11500	Indirect
Common Stock	100000	Indirect